An Open-label Single-arm Sequential Single-center Clinical Trial of the Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection (PEX168) in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 03 Dec 2016
At a glance
- Drugs PEG loxenatide (Primary) ; Digoxin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 28 Nov 2016 Status changed from recruiting to completed.
- 08 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 26 May 2015 New trial record